AstraZeneca and Bristol-Myers Squibb complete expansion of diabetes alliance
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
List view / Grid view
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
8 August 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced the successful completion of the tender offer...
6 August 2012 | By Bristol-Myers Squibb Company
$1.6 million awarded in grants...
1 August 2012 | By Bristol-Myers Squibb Company
Administration of study drug suspended...
30 July 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca announced the results of analyses...
19 July 2012 | By Bristol-Myers Squibb Company
Results of the phase III BRISK-FL clinical trial...
10 July 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin...
30 June 2012 | By AstraZeneca
Bristol-Myers Squibb to acquire Amylin...
26 June 2012 | By Bristol-Myers Squibb Company / Pfizer
Additional information requested from ARISTOTLE trial results...
21 June 2012 | By Bristol-Myers Squibb Company
First studies under the agreement to focus on clinical trial programs in oncology...
9 June 2012 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb Company announced results from a Phase 3 clinical study...
6 June 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company have announced the results of AMPLE...
15 May 2012 | By Bristol-Myers Squibb Company
Expansion of Together on Diabetes® initiative to China and India ...
15 May 2012 | By Bristol-Myers Squibb Company
State-of the art Manufacturing Facility Supports Company’s Growing Focus on Biologics...
14 May 2012 | By Bristol-Myers Squibb
Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University’s School of Life Sciences...